HYTN Innovations Inc. (HYTN:CC) | Stock Information | Vox Markets
Vox Markets

HYTN Innovations Inc.

HYTN:CC

Recent News

CompanyTitleDate
HYTNHYTN Announces Arrangement Agreement to Facilitate the Spin-Out of a Peptide-Focused Drug Development BusinessSep 2, 2026
HYTNHYTN HYTN Innovations Inc. - CSE Form 7 - Monthly Progress Report for May 2026Jun 3, 2026
HYTNHYTN HYTN Innovations Inc. - CSE Form 5 - Quarterly Listing StatementJun 3, 2026
HYTNHYTN HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical OilsMay 7, 2026
HYTNHYTN HYTN Innovations Inc. - CSE Form 7 - Monthly Progress Report for April 2026May 5, 2026
HYTNHYTN HYTN Successfully Exports GMP-Manufactured Vape CartridgesApr 30, 2026
HYTNHYTN HYTN Innovations Inc. - CSE Form 10 - Notice of Proposed Significant TransactionApr 24, 2026
HYTNHYTN HYTN Announces Extension of Marketing ProgramApr 24, 2026
HYTNHYTN HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development BusinessApr 23, 2026
HYTNHYTN HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in GermanyApr 17, 2026
HYTNHYTN HYTN Innovations Inc. - CSE Form 7 - Monthly Progress Report for March 2026Apr 2, 2026
HYTNHYTN HYTN Successfully Releases Cannabis Products in Germany and Accepts ReorderMar 27, 2026
HYTNHYTN HYTN Innovations Inc. - CSE Form 10 - Notice of Proposed Significant TransactionMar 23, 2026
HYTNHYTN HYTN Appoints Fabian Monaco to Board of DirectorsMar 20, 2026

Overview

Classification

Sector Healthcare

Industry Pharmaceuticals

Subindustry Pharmaceutical Manufacturers - Cannabis

Financials